Novel T-Cell Therapy Promising in Tough-to-Treat Eye Cancer



(MedPage Today) — BERLIN — A single infusion of the investigational PRAME-directed T-cell receptor T-cell therapy anzutresgene autoleucel (anzu-cel) showed encouraging antitumor activity in patients with previously treated advanced or metastatic…



Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118094

Author :

Publish date : 2025-10-22 21:23:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version